Typical type 2 diabetes mellitus and HFE gene mutations: A population-based case - Control study

Human Molecular Genetics

Volumn 12, Issue 12, 2003, Pages 1361-1365

  Halsall, David J ^a   McFarlane, Ian ^a   Luan, Jian'an ^b   Cox, Timothy M ^a   Wareham, Nicholas J ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN; INSULIN; IRON;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT LOADING; ONSET AGE; PATHOGENESIS; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL;

AGE OF ONSET; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POINT MUTATION;

EID: 0037701646     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ajioka, R.S. and Kushner, J.P. (2002) Hereditary hemochromatosis. Semin. Hematol., 39, 235-241.
2. Saudek, C.D. and Charache, S. (1992) Haemochromatosis and diabetes. Baillieres Clin. Endocrinol. Metab., 6, 807-817.
3. Hanson, E.H., Imperatore, G. and Burke, W. (2001) HFE gene and hereditary hemochromatosis: a HuGE review. Am. J. Epidemiol., 154, 193-206.
4. Beutler, E., Felitti, V.J., Koziol, J.A., Ho, N.J. and Gelbart, T. (2002) Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet, 359, 211-218.
5. Jackson, H.A., Carter, K., Darke, C., Guttridge, M.G., Ravine, D., Hutton, R.D., Napier, J.A. and Worwood, M. (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br. J. Haematol., 114, 474-484.
6. Asberg, A., Hveem, K., Thorstensen, K., Ellekjter, E., Kannelonning, K., Fjosne, U., Halvorsen, T.B., Smethurst, H.B., Sagen, E. and Bjerve, K.S. (2001) Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand. J. Gastroenterol., 36, 1108-1115.
7. Moczulski, D.K., Grzeszczak, W. and Gawlik, B. (2001) Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care, 24, 1187-1191.
8. Behn, P., Glaser, B. and Permutt, M. (1998) Contribution of the C282Y Hereditary Haemochromatosis mutation to type 2 diabetes mellitus in Ashkenasi Jews. Diabetes, 47, 1523.
9. Braun, J., Donner, H., Plock, K., Rau, H., Usadel, K.H. and Badenhoop, K. (1998) Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus. Diabetologia, 41, 983-984.
10. Dubois-Laforgue, D., Caillat-Zucman, S., Djilali-Saiah, I., Larger, E., Mercadier, A., Boitard, C., Bach, J.F. and Timsit, J. (1998) Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM. Diabetes Care, 21, 1371-1372.
11. Fernandez-Real, J.M., Vendrell, J., Baiget, M., Gimferrer, E. and Ricart, W. (1999) C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. Diabetes Care, 22, 525-526.
12. Florkowski, C.M., George, P.M., Willis, J.A., Stott, M.K., Burt, M.J., Upton, J.D., Nesbit, J., Walmsley, T.A. and Scott, R.S. (1999) Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diabetes Res. Clin. Pract., 43, 199-203.
13. Frayling, T., Ellard, S., Grove, J., Walker, M. and Hattersley, A.T. (1998) C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet, 351, 1933-1934.
14. Kwan, T., Leber, B., Ahuja, S., Carter, R. and Gerstein, H.C. (1998) Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clin. Invest. Med., 21, 251-257.
15. Sampson, M.J., Williams, T., Heyburn, P.J., Greenwood, R.H., Temple, R.C., Wimperis, J.Z., Jennings, B.A. and Willis, G.A. (2000) Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes. J. Lab. Clin. Med., 135, 170-173.
16. Njajou, O.T., Alizadeh, B.Z., Vaessen, N., Vergeer, J., Houwing-Duistermaat, J., Hofman, A., Pols, H.A. and Van Duijn, C.M. (2002) The role of hemochromatosis C282Y and H63D gene mutations in type 2 diabetes: findings from the Rotterdam Study and meta-analysis. Diabetes Care, 25, 2112-2113.
17. Salonen, J.T., Tuomainen, T.P. and Kontula, K. (2000) Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. Br. Med. J., 320, 1706-1707.
18. Worwood, M. (2002) HFE Mutations as risk factors in disease. Best Pract. Res. Clin. Haematol., 15, 295-314.
19. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R. Jr, Ellis, M.C., Fullan, A. et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet, 13, 399-408.
20. Merryweather-Clarke, A.T., Pointon, J.J., Shearman, J.D. and Robson, K.J. (1997) Global prevalence of putative haemochromatosis mutations. J. Med. Genet., 34, 275-278.
21. Alberti, K.G. and Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet. Med, 15, 539-553.
22. Ellervik, C., Mandrup-Poulsen, T., Nordestgaard, B.G., Larsen, L.E., Appleyard, M., Frandsen, M., Petersen, P., Schlichting, P., Saermark, T., Tybjaerg-Hansen, A. et al. (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet, 358, 1405-1409.
23. Eshed, I., Elis, A. and Lishner, M. (2001) Plasma ferritin and type 2 diabetes mellitus: a critical review. Endocr. Res., 27, 91-97.
24. George, D.K., Evans, R.M., Crofton, R.W. and Gunn, I.R. (1995) Testing for haemochromatosis in the diabetic clinic. Ann. Clin. Biochem., 32, 521-526.
25. Turnbull, A.J., Mitchison, H.C., Peaston, R.T., Lai, L.C., Bennett, M.K., Taylor, R. and Bassendine, M.F. (1997) The prevalence of hereditary haemochromatosis in a diabetic population. Q. J. Med., 90, 271-275.
26. Fernandez-Real, J.M., Penarroja, G., Castro, A., Garcia-Bragado, F., Hernandez-Aguado, I. and Ricart, W. (2002) Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes, 51, 1000-1004.
27. Dubois-Laforgue, D., Caillat-Zucman, S., Boitard, C. and Timsit, J. (2000) Clinical characteristics of type 2 diabetes in patients with mutations of HFE. Diabetes Metab., 26, 65-68.
28. Rathmann, W., Haastert, B., Icks, A., Giani, G., Hennings, S., Mitchell, J., Curran, S. and Wareham, N.J. (2001) Low faecal elastase 1 concentrations in type 2 diabetes mellitus. Scand. J. Gastroenterol., 36, 1056-1061.
29. Lucotte, G. (1998) Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol. Dis., 24, 433-438.
30. Jazwinska, E.C., Cullen, L.M., Busfield, F., Pyper, W.R., Webb, S.I., Powell, L.W., Morris, C.P. and Walsh, T.P. (1996) Haemochromatosis and HLA-H. Nat. Genet., 14, 249-251.
31. Hedges, L.V., and Olkin, I. (1985) Statistical Methods for Meta-Analysis. Academic Press, San Diego, CA.